Novo CEO pressed by Senate to chop rates of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen advised lawmakers the corporation would take into consideration new talks with insurers regarding the record costs of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. https://kethek.com/